Provided by Tiger Trade Technology Pte. Ltd.

Illumina

134.46
+7.065.54%
Post-market: 134.570.1100+0.08%19:54 EST
Volume:4.01M
Turnover:533.71M
Market Cap:20.55B
PE:24.67
High:134.76
Open:127.97
Low:127.00
Close:127.40
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:1.69
T/O Rate:2.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.39%
PB:7.55
PE(LYR):24.67

Loading ...

Illumina Secures Reimbursement of Nearly $3,000 Per TruSight Test

MT Newswires Live
·
Jan 20

BRIEF-Illumina Secures CMS Reimbursement For TruSight Oncology Comprehensive, Expanding Access To Precision Oncology

Reuters
·
Jan 20

Illumina Inc - FDA-Approved Test Reimbursed at $2,989.55 per Test

THOMSON REUTERS
·
Jan 20

Illumina Secures CMS Reimbursement for Trusight™ Oncology Comprehensive, Expanding Access to Precision Oncology

THOMSON REUTERS
·
Jan 20

Illumina price target raised to $155 from $135 at Stifel

TIPRANKS
·
Jan 20

FACTBOX-Pharma sector doubles down on AI amid hopes of slashing costs, timelines

Reuters
·
Jan 16

Illumina (ILMN) Valuation Check After Recent Share Price Rebound And Conflicting Fair Value Signals

Simply Wall St.
·
Jan 15

Illumina: Rich Valuation Amid Mounting Competitive and Execution Risks Supports Sell Rating

TIPRANKS
·
Jan 14

BUZZ-Illumina rises after forecasting Q4 results beat

Reuters
·
Jan 13

Illumina Shares up Nearly 3% After Co Reports Preliminary Q4 Revenue, Profit Above Estimates

THOMSON REUTERS
·
Jan 13

Illumina sees Q4 non-GAAP EPS $1.27-$1.30, consensus $1.21

TIPRANKS
·
Jan 13

Illumina Unveils Billion Cell Atlas to Power AI-Driven Drug Discovery

Reuters
·
Jan 13

BRIEF-Illumina Introduces Billion Cell Atlas, Genome-Wide Genetic Perturbation Dataset

Reuters
·
Jan 13

Illumina: Alliance Framework With AstraZeneca, Merck, & Eli Lilly Leading as Founding Participants for Billion Cell Atlas

THOMSON REUTERS
·
Jan 13

Illumina Q4 preliminary revenue rises 5%, beats analyst expectations

Reuters
·
Jan 13

GUIDANCE: (ILMN) Illumina Expects 2025 Revenue About $4.34B, vs. FactSet Est of $4.28B

MT Newswires Live
·
Jan 13

GUIDANCE: (ILMN) Illumina Expects Q4 Adjusted EPS Range $1.27 to $1.30, vs. FactSet Est of $1.21

MT Newswires Live
·
Jan 13

Illumina posts Q4 revenue of USD 1.16 billion, up 5 percent

Reuters
·
Jan 13

BRIEF-Illumina Q4 Revenue USD 1,155 Million Vs. IBES Estimate USD 1,094 Million

Reuters
·
Jan 13

Illumina Inc - FY 2025 Non-Gaap EPS $4.76-$4.79

THOMSON REUTERS
·
Jan 13